Ladenburg Thalmann Financial Services’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1K Hold
150
﹤0.01% 5172
2019
Q3
$0 Hold
150
﹤0.01% 5280
2019
Q2
$1K Hold
150
﹤0.01% 5078
2019
Q1
$1K Sell
150
-200
-57% -$780 ﹤0.01% 5045
2018
Q4
$1K Hold
350
﹤0.01% 5010
2018
Q3
$2K Buy
350
+200
+133% +$1.11K ﹤0.01% 4850
2018
Q2
$1K Hold
150
﹤0.01% 4958
2018
Q1
$1K Buy
+150
New +$662 ﹤0.01% 4958
2017
Q3
Sell
-50
Closed 4930
2017
Q2
$0 Hold
50
﹤0.01% 4873
2017
Q1
$0 Hold
50
﹤0.01% 4844
2016
Q4
$0 Hold
50
﹤0.01% 4847
2016
Q3
$0 Buy
+50
New +$381 ﹤0.01% 4773

Other funds holding CATX

Ladenburg Thalmann Financial Services's CATX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Perspective Therapeutics (CATX) position steady in Q4 2019 at 150 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5172.

Ladenburg Thalmann Financial Services first reported a position in CATX in Q3 2016 and has held it in 12 quarters since. The position peaked at $2K in Q3 2018. 31 funds tracked by Wall St. Rank hold CATX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 150 shares of Perspective Therapeutics worth $1K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Perspective Therapeutics share count unchanged in Q4 2019.
  • Perspective Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5172 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Perspective Therapeutics in Q3 2016 and has held it in 12 quarters since.
  • Ladenburg Thalmann Financial Services's Perspective Therapeutics position peaked at $2K in Q3 2018.
  • 31 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.